TrialCancer control : journal of the Moffitt Cancer Center

A Non-Inferior Randomized Trial of Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Premenopausal Patients With Hormone-Responsive and HER2-Negative Lymph Node-Negative Breast Cancer.

Chongshan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.